Category: PMCPA Case of the Week

Cases selected for the AskAnzal weekly PMCPA insight newsletter

8 Mar 2026

Pfizer: sponsored nurse audit programmes and β€œvalue added” services linked to Lipitor targeting (AUTH/1807/3/06 & AUTH/1810/3/06)

Sunday Times alleged nurses were paid/bonused to influence prescribing. Panel found most audits acceptable, but breached the Code…

8 Mar 2026

AUTH/1797/2/06: Editor of a Pharmacy Journal v Bayer (Levitra) β€” celebrity endorsement complaint (No breach)

Complaint about celebrity comments praising Levitra in BBC and Saga online articles linked to SortEDin10. PMCPA ruled celebrity…

8 Mar 2026

Abbott: media report of gay bar visit with consultant led to hospitality complaint (Appeal Board: no breach)

The Sun alleged Abbott reps attended a Glasgow gay bar with a hospital consultant. Panel found hospitality/Clause 2…

8 Mar 2026

Leo Pharma: MSL activity deemed promotional, triggering ABPI exam requirement (AUTH/3244/9/19)

Anonymous employee complaint about Leo’s dermatology MSLs. Panel found some MSL speaker-meeting activity was promotional, so MSLs should…

8 Mar 2026

AUTH/3363/6/20: GSK Anoro Ellipta public website page – no breach (reference information and certification upheld)

A UK health professional alleged GSK’s public Anoro Ellipta webpage promoted a POM and encouraged requests for treatment,…

8 Mar 2026

Novartis: corporate webpage pipeline table ruled to promote POMs to the public and an unlicensed medicine (AUTH/3414/11/20)

Novartis’ corporate webpage listed pipeline products with indications and trial details. PMCPA ruled it promoted two licensed POMs…

8 Mar 2026

AstraZeneca: β€œNon-promotional” EAP webinar ruled promotional and disguised promotion (Calquence) (AUTH/3521/6/21)

An invitation-only Calquence EAP β€œnon-promotional” webinar used positive case studies and lacked certified slides. PMCPA ruled it was…

8 Mar 2026

AUTH/3653/5/22: Eli Lilly v Novo Nordisk β€” GLP-1RA supply emails ruled disparaging (Clause 6.6)

Novo Nordisk emailed HCPs about GLP-1RA supply during Lilly’s Trulicity dose outage. Panel found the wording implied Lilly…

8 Mar 2026

AstraZeneca: UK employees’ LinkedIn β€˜likes’ brought US FDA approval post into ABPI Code scope (AUTH/3707/11/22)

A US-facing LinkedIn post about an FDA-approved lung cancer combo was liked/commented on by 14 UK-based AstraZeneca employees,…

8 Mar 2026

GSK: UK employees’ LinkedIn β€˜likes’ brought global Jemperli post into scope and amounted to POM promotion to the public (AUTH/3810/8/23)

Two UK-based GSK employees β€˜liked’ a LinkedIn post about US FDA approval for Jemperli + chemotherapy. Panel ruled…

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training